Development Scientist - US (1 Year Contract) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Lucence · 1 month ago

Development Scientist - US (1 Year Contract)

positionPalo Alto, CA
timeFull-time, Contract
remoteOnsite
seniorityEntry, Mid Level
date2+ years exp

Lucence is a pioneering precision oncology company focused on early detection and timely treatment of cancer. As a Development Scientist, you will develop and implement clinical assays to advance cancer care.

BiotechnologyGeneticsHealth CareHealth DiagnosticsMedical
check
H1B Sponsor Likelynote

Responsibilities

Design and conduct laboratory experiments to develop new clinical assays
Plan and lead assay validation studies
Troubleshoot and resolve technical challenges during assay development
Drive the automation of novel assays
Maintain accurate and organized experimental records
Prepare detailed protocols and validation reports to ensure regulatory compliance
Train staff and facilitate assay transfer from R&D to clinical operations

Qualification

Molecular BiologyClinical Assays DevelopmentPCRNGSRegulatory ComplianceRPythonResilienceCommunicationQuick LearningSelf-MotivationAdaptability

Required

A PhD in Molecular Biology, Cancer Biology, Genomics, or related field
A proven track record of quick learning
Strong background in molecular biology, including PCR, RT-PCR, genotyping and NGS
At least 2 years of working experience in the development of clinical assays, with significant hands-on expertise in troubleshooting, optimizing, and validating molecular assays
Good understanding of the regulatory and quality requirements of clinical diagnostics
Strong self-motivation, resilience, adaptability, and a keen interest in learning
Excellent communication and presentation skills

Preferred

A deep understanding and knowledge of oncology and/or genomics
Proficiency in R or Python
Fluency in variant annotation and interpretation and use of genome databases such as COSMIC, ClinVar, Varsome, Ensembl, and OncoKB
Ability to interpret genomic data in patient- and treatment-specific contexts

Company

Lucence

twittertwittertwitter
company-logo
Lucence is a precision health company, using proprietary AI-powered liquid biopsy technology to detect cancers earlier when outcomes are better.
dateFounded in 2016
location
Palo Alto, California, USA
people-size51-200 employees
web-link
https://www.lucence.com/

H1B Sponsorship

Lucence has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2023 (2)
2022 (1)

Funding

Current Stage
Growth Stage
Total Funding
$29.2M
Key Investors
IHH Healthcare Berhad
2019-11-20Series A· $20M
2019-01-01Seed· $9.2M

Leadership Team

leader-logo
Min-Han Tan
CEO and Medical Director
linkedin

Recent News

PR Newswire
Multi Cancer Early Detection Testing Market to Reach US$ 7.52 Billion by 2033 as Galleri, CancerSEEK, and Next-Gen Liquid Biopsies Lead Global Adoption
2025-10-09
GlobeNewswire News Room
Liquid Biopsy Market Projected to Reach USD 21.78 Billion by 2032 Amid Rising Demand for Non-Invasive Cancer Diagnostics – SNS Insider
2025-03-20
GlobeNewswire News Room
Tumor Profiling Market Projected to Surpass USD 24.8 Billion by 2032, Driven by Advancements in Precision Oncology – SNS Insider
2025-02-26
Company data provided by crunchbase